Check out the companies that make headlines before the opening bell. The transaction is expected to close in the fourth quarter. Pfizer’s shares rose almost 3%. Compass everywhere – Broker giant Compass plans to take over rivals everywhere, the parent of Century 21 and Coldwell Bunker. The total company is expected to have a corporate value of approximately $10 billion, including debt assumptions. Compass stocks won over 50%, while Compass stocks fell about 9%. Sarepta Therapeutics – Biotechnology companies rose 6% after upgrading to BMO outperform. “The current assessment of SRPT is skewed into benefits in risk/reward,” the investment bank said. Crown Castle – Cell Tower operators performed from Peer Perform with an additional 1.1% behind Wolfe Research. Wolf said the stocks are trading at a good entrance. KENVUE – Tylenol makers fell 5% after the Washington Post reported on Monday that the Trump administration is scheduled to announce that painkillers use by pregnant women is linked to autism. Fox Corporation – President Donald Trump said in an interview Sunday that conservative Media Baron Rupert Murdoch and his son Lachlan, the CEO of Fox Corporation, are likely involved in a contract to save U.S. Tiktok. Fox Corp’s shares won nearly 4% in pre-market trading. Applicable Materials – After Morgan Stanley upgrades were upgraded from equal weight to overweight, the shares were acquired over 1%. Investment banks noted that chipmakers are trading at an attractive rating compared to peers. – Reported by CNBC’s Alex Hurling, Fred Inbert and Michelle Fox.
